[1]
A. Pękala, “Monitoring of infliximab treatment in inflammatory bowel diseases – basic knowledge and current data based on clinical trials in a population of Polish patients”, Eur J Clin Exp Med, vol. 20, no. 3, pp. 251–259, Sep. 2022.